Phase I clinical trial shows promising results for a universal flu vaccine, capable of inducing a broad antibody response against several types of currently circulating human influenza virus, as well as avian and bat influenza virus subtypes.

Phase I clinical trial shows promising results for a universal flu vaccine, capable of inducing a broad antibody response against several types of currently circulating human influenza virus, as well as avian and bat influenza virus subtypes.
top scoring links : multi

Related posts

Leave a Comment